Pharmacy: Improving Medication Adherence, Overcoming Obstacles and Designing Effective Pharmacy-Based Programs

February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p46
Trade Publication
The article presents a discussion paper prepared by McKesson Corp. in cooperation with pharmaceutical industry representatives in the U.S. It highlights the topics covered by the discussion paper which include the improvement in medication adherence and the design of effective pharmacy-based programs. It outlines the role of pharmacists in promoting medication adherence programs.


Related Articles

  • 'We'e positioned to help our customers communicate.  // Chain Drug Review;6/7/2010, Vol. 32 Issue 10, p50 

    The article reports on the importance of increasing patient compliance to the prescribed medications which is a core function of McKesson Corp. in the U.S.

  • Breaking the Mold. Koroneos, George // Pharmaceutical Representative;Oct2010, Vol. 40 Issue 10, p12 

    The article focuses on the role of pharmacists and representatives in providing medical care for patients along with healthcare professionals in the industry. It stresses that medication compliance is the priority concern of most physicians and allied healthcare professionals since most of the...

  • PhRMA, BIO Lend Voices To Public Policy Debate.  // Chain Drug Review;8/27/2012, Vol. 34 Issue 14, p114 

    The article focuses on the issues being addressed by the Pharmaceutical Research and Manufacturers of America (PhRMA) and its member companies, which includes access and affordability, patient adherence to medications and drug safety.

  • Product safety is a priority.  // Chain Drug Review;6/7/2010, Vol. 32 Issue 10, p49 

    The article reports on the determined commitment of McKesson Corp. to deliver and ensure safe, efficient and cost effective medications to their custormers in the U.S.

  • Rx Wholesalers Zero In on Performance.  // Chain Drug Review;1/20/2014, Vol. 36 Issue 2, p34 

    The article informs that the three major pharmaceutical wholesalers in the U.S. including McKesson Corp. and AmerisourceBergen Corp. have partnered with Pharmacy Quality Solutions Inc. (PQS) to help pharmacies in improving their performance on Medicare Part D Star Ratings, as of January 2014.

  • Patient-Centric Adherence. Aitken, Murray // Chain Drug Review;11/19/2012, Vol. 34 Issue 20, p51 

    The article discusses the issues related with need of medication adherence program to keep health costs in check and it also presents the views of Peggy Yelinek, vice president and general manager of McKesson Patient Relationship Solutions at McKesson Corp., regarding the same.

  • Rx intervention program improves outcomes.  // Chain Drug Review;4/22/2013, Vol. 35 Issue 7, p166 

    The article offers information on the Pharmacy Intervention Program (PIP) of health care service provider McKesson Corp. which focuses on achieving patient adherence through interventions by the pharmacists who are trained in motivational interviewing.

  • Better adherence would be boon for pharmaceutical industry.  // Chain Drug Review;1/7/2013, Vol. 35 Issue 1, p70 

    The article informs about the report which provides insights into the significant revenue loss to pharmaceutical firms in the U.S. as a result of medication nonadherence.

  • Keeping patients on their meds is high priority.  // Chain Drug Review;4/22/2013, Vol. 35 Issue 7, p165 

    The article informs that according to Kevin Kettler, senior vice president at McKesson Corp., the company is focused on dealing with medication adherence issues by supporting the pharmacists with mobile and online technologies.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics